Description

According to StrategyHelix, the global sleep aids market is expected to increase by US$ 39.7 billion during 2022-2028, expanding at a CAGR of 6.6% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for sleep aids. The global sleep aids market is segmented on the basis of product, sleep disorder, and region. Based on product, the global sleep aids market is categorized into mattress & pillows, sleep laboratories, medications, sleep apnea devices, others. Globally, the mattress & pillows segment made up the largest share of the sleep aids market. On the basis of sleep disorder, the global sleep aids market has been segmented into insomnia, narcolepsy, restless legs syndrome (RLS), sleep apnea, others. The insomnia segment captured the largest share of the market in 2021. Geographically, the global sleep aids market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, North America had the largest share in the global sleep aids market.

The global sleep aids market is highly competitive. The sleep aids market is dominated by key players, which are Advanced Brain Monitoring Inc., Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Laboratories Inc., Fisher & Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Pfizer Inc, ResMed Inc., Sanofi S.A. Competitive landscape gives a description of the competitive nature of the global sleep aids market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the sleep aids market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: mattress & pillows, sleep laboratories, medications, sleep apnea devices, others
Sleep disorder: insomnia, narcolepsy, restless legs syndrome (RLS), sleep apnea, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Advanced Brain Monitoring Inc., Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Laboratories Inc., Fisher & Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Pfizer Inc, ResMed Inc., Sanofi S.A.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global sleep aids market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Sleep aids market overview
Part 3. Market breakdown by product
– Mattress & pillows
– Sleep laboratories
– Medications
– Sleep apnea devices
– Others
Part 4. Market breakdown by sleep disorder
– Insomnia
– Narcolepsy
– Restless legs syndrome (RLS)
– Sleep apnea
– Others
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– Advanced Brain Monitoring, Inc.
– Apnea Sciences Corporation
– Boehringer Ingelheim International GmbH
– Cadwell Laboratories, Inc.
– Fisher & Paykel Healthcare Corporation Limited
– Natus Medical Incorporated
– Nihon Kohden Corporation
– Pfizer, Inc
– ResMed Inc.
– Sanofi S.A.
About StrategyHelix
Disclaimer